158 related articles for article (PubMed ID: 25637367)
1. An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality.
Sung KC; Ryu S; Wild SH; Byrne CD
Heart; 2015 Apr; 101(7):553-8. PubMed ID: 25637367
[TBL] [Abstract][Full Text] [Related]
2. Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis.
Sung KC; Wild SH; Byrne CD
Atherosclerosis; 2013 Dec; 231(2):181-6. PubMed ID: 24267222
[TBL] [Abstract][Full Text] [Related]
3. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
[TBL] [Abstract][Full Text] [Related]
4. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
[TBL] [Abstract][Full Text] [Related]
5. Association between serum C-peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals.
Li Y; Li Y; Meng L; Zheng L
PLoS One; 2015; 10(1):e112281. PubMed ID: 25559358
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
[TBL] [Abstract][Full Text] [Related]
7. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
[TBL] [Abstract][Full Text] [Related]
8. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
[TBL] [Abstract][Full Text] [Related]
9. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
[TBL] [Abstract][Full Text] [Related]
10. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
[TBL] [Abstract][Full Text] [Related]
11. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
Oksala N; Seppälä I; Hernesniemi J; Lyytikäinen LP; Kähönen M; Mäkelä KM; Reunanen A; Jula A; Ala-Korpela M; Lehtimäki T
Ann Med; 2013 Mar; 45(2):141-8. PubMed ID: 22524251
[TBL] [Abstract][Full Text] [Related]
12. Apoprotein B/Apoprotein A-1 Ratio and Mortality among Prevalent Dialysis Patients.
Sato Y; Fujimoto S; Toida T; Nakagawa H; Yamashita Y; Iwakiri T; Fukuda A; Iwatsubo S
Clin J Am Soc Nephrol; 2016 May; 11(5):840-846. PubMed ID: 26912548
[TBL] [Abstract][Full Text] [Related]
13. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
Mora S; Buring JE; Ridker PM; Cui Y
Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
[TBL] [Abstract][Full Text] [Related]
14. The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population.
Okamura T; Hayakawa T; Kadowaki T; Kita Y; Okayama A; Ueshima H;
Atherosclerosis; 2006 Jan; 184(1):143-50. PubMed ID: 15913635
[TBL] [Abstract][Full Text] [Related]
15. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E predicts incident cardiovascular disease risk in women but not in men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein.
Corsetti JP; Gansevoort RT; Bakker SJ; Navis G; Sparks CE; Dullaart RP
Metabolism; 2012 Jul; 61(7):996-1002. PubMed ID: 22225956
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipoprotein levels as predictors of cardiovascular death in women.
Bass KM; Newschaffer CJ; Klag MJ; Bush TL
Arch Intern Med; 1993 Oct; 153(19):2209-16. PubMed ID: 8215724
[TBL] [Abstract][Full Text] [Related]
18. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality.
Silbernagel G; Schöttker B; Appelbaum S; Scharnagl H; Kleber ME; Grammer TB; Ritsch A; Mons U; Holleczek B; Goliasch G; Niessner A; Boehm BO; Schnabel RB; Brenner H; Blankenberg S; Landmesser U; März W
Eur Heart J; 2013 Dec; 34(46):3563-71. PubMed ID: 24014391
[TBL] [Abstract][Full Text] [Related]
19. Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patients.
Chang TI; Streja E; Soohoo M; Ko GJ; Rhee CM; Kovesdy CP; Kashyap ML; Vaziri ND; Kalantar-Zadeh K; Moradi H
J Clin Lipidol; 2018; 12(2):488-497. PubMed ID: 29456130
[TBL] [Abstract][Full Text] [Related]
20. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
